Cetrorelix acetate

Bezeichnung:Cetrorelix acetate

CAS-Nr120287-85-6

Englisch Name:Cetrorelix acetate

CBNumberCB0316370

SummenformelC70H92ClN17O14

Molgewicht1431.04

MOL-Datei120287-85-6.mol

Cetrorelix acetate physikalisch-chemischer Eigenschaften

Schmelzpunkt	>259°C (dec.)
Dichte	1.42±0.1 g/cm3(Predicted)
storage temp.	Refrigerator
Löslichkeit	DMSO (Slightly, Heated), Methanol (Very Slightly)
Aggregatzustand	Solid
pka	9.82±0.15(Predicted)
Farbe	White to Off-White
InChIKey	SBNPWPIBESPSIF-MHWMIDJBSA-N

Sicherheit

Giftige Stoffe Daten

120287-85-6(Hazardous Substances Data)

Gefahreninformationscode (GHS)

Cetrorelix acetate Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung
Cetrorelix was launched in Germany for the treatment of female infertility. It is a decapeptidic analog of luteinizing hormone-releasing hormone (LH-RH) bearing structural modifications in the crucial positions 1, 2, 3, 6 and 10 : [Ac-D-Nal1, D-4-CI Phe-2, D-Pal3, D-Cit6, D-Alal0]-GnRH. Cetrorelix is an extremely potent and long acting gonadotrophin releasing hormone (GnRH) antagonist and thus blocks gonadotrophins and sex steroid secretion immediately after administration. Moreover, it has a low histamine-releasing potency. Cetrorelix will be the first LH-RH antagonist approved worldwide. In several Phase III clinical trials, female patients receiving Cetrorelix had a successful controlled ovulation thus avoiding a premature LH-surge. Cetrorelix could be a first-choice in-vitro fertilization (IVF) treatment without the complications of current controlled ovarian hyperstimulation protocols. Cetrorelix is currently under clinical investigation for the treatment of diverse sex hormone dependent disorders such as benign prostate hypertrophy, breast, ovarian or prostate cancers and diverse gynaecological disorders.
Originator
Asta Medica (Germany)
Verwenden
Cetrorelix Acetate is an gonadotropin-releasing hormone antagonist and is used to treat hormone-sensitive cancers of the prostate and breast.
Definition
ChEBI: A synthetic ten-membered oligopeptide comprising N-acetyl-3-(naphthalen-2-yl)-D-alanyl, 4-chloro-D-phenylalanyl, 3-(pyridin-3-yl)-D-alanyl, L-seryl, L-t rosyl, N5-carbamoyl-D-ornithyl, L-leucyl, L-arginyl, L-prolyl, and D-alaninamide residues coupled in sequence. A gonadotrophin-releasing hormone (GnRH antagonist, it is used for treatment of infertility and of hormone-sensitive cancers of the prostate and breast.
Trademarks
Cetrotide (Serono).

Cetrorelix acetate Upstream-Materialien And Downstream Produkte

Cetrorelix acetate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

120287-85-6, Cetrorelix acetate Verwandte Suche:

Send Inquriy